Aug 10, 2022 / 12:00PM GMT
Operator
Good day, and welcome to Haemonetics Corporation's First Quarter Fiscal 2023 Earnings Call. (Operator Instructions) After the speakers' presentation, there will be a question-and-answer session. As a reminder, this call is being recorded.
I would like to turn the call over to Olga Guyette, Senior Director of Investor Relations and Treasury. You may begin.
Olga Guyette - Haemonetics Corporation - Director of IR
Good morning, everyone. Thank you for joining us for Haemonetics' First Quarter Fiscal '23 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; and James D'Arecca, our CFO.
This morning, we posted our first quarter fiscal '22 results to our Investor Relations website, along with updates for fiscal '23 guidance in analytical tables with information that we'll refer to on this call. Additionally, we provided a complete P&L, balance sheet, summary statement of cash flows as well as reconciliations of our GAAP to non-GAAP financial results and guidance.
Before we get started, unless otherwise noted, all
Q1 2023 Haemonetics Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot